Effect of oral magnesium supplementation on the lipid profile and blood glucose of patients with type 2 diabetes mellitus

Journal of Association of Physicians of India

Volumn 51, Issue JAN, 2003, Pages 37-42

  Lal, J ^a   Vasudev, Kamini ^a   Kela, A K ^a   Jain, S K ^a  

^a LADY HARDINGE MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; MAGNESIUM;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BLOOD; BLOOD PRESSURE; BODY MASS; CASE CONTROL STUDY; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADULT; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LIPIDS; MAGNESIUM; MALE; MIDDLE AGED;

EID: 0038179873     PISSN: 00045772     EISSN: 00045772     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Mykkanen L, Kuusisto J, Pyorala K, Laakso M. Cardiovascular disease risk factors as predictors of type 2 (non-insulin-dependent) diabetes mellitus in elderly subjects. Diabetologia 1993;36:553-9.
2. Feingold KR, Grunfield C, Pang M, Doerrler W, Krauss RM. LDL subclass phenotypes and triglyceride metabolism in non-insulin-independent diabetes. Arterioscler Thromb 1992;12:1496-502.
3. Dunn FL, Raskin P, Bilheimer DW, Grundy SM. The effect of diabetic control on very low-density lipoprotein-triglyceride metabolism in patients with type II diabetes mellitus and marked hypertriglyceridemia. Metabolism 1984;33:117-23.
4. Niskanen L, Uusitupa M, Sarlund H, et al. Microalbuminuria predicts the development of serum lipoprotein abnormalities favouring atherogenesis in newly diagnosed type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1990;33:237-43.
5. Lima M de L, Cruz T, Pousada JC, Rodrigues LE, Barbosa K, Cangucu V. The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes. Diabetes Care 1998;21:682-6.
6. deValk HW. Hypomagnesaemia and type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1992;35:904-5.
7. White JR Jr, Campbell RK. Magnesium and diabetes: a review. Ann Pharmacother 1993;27:775-80.
8. Nadler JL, Malayan S, Luong H, Shaw S, Natarajan RD, Rude RK. Intracellular free magnesium deficiency plays a key role in increased platelet reactivity in type II diabetes mellitus. Diabetes Care 1992;15:835-41.
9. Alzaid AA, Dinneen SF, Moyer TP, Rizza RA. Effects of insulin on plasma magnesium, in non-insulin dependent diabetes mellitus: evidence for insulin resistance. J Clin Endocrinol Metab 1995;80:1376-81.
10. Nakamura M, Ishihara Y, Sata T, Torii S, Sumiyoshi A, Tanaka K. Effects of dietary magnesium and glycyrrhizin on experimental atheromatosis of rats (long-term experiment). Jpn Heart J 1996;7:474-86.
11. Itoh K, Kawasaka T, Nakamura M. The effects of high oral magnesium supplementation on blood pressure, serum lipids and related variables in apparently healthy Japanese subjects. Br J Nutr 1997;78:737-50.
12. Corica F, Allegra A, Di Benedetto A, et al. Effects of oral magnesium supplementation on plasma lipid concentrations in patients with non-insulin-dependent diabetes mellitus. Magnes Res 1994;7:43-7.
13. Purvis JR, Cummings DM, Landsman P, et al. Effect of oral magnesium supplementation on selected cardiovascular risk factors in non-insulin-dependent diabetics. Arch Fam Med 1994;3:503-8.
14. de Valk HW, Verkaaik R, Van Rijn HJ, Geerdink RA, Struyvenberg A. Oral mangnesium supplementation in insulin-requiring Type-2 diabetic patients. Diabet Med 1998;15:503-7.
15. Yajnik CS, Smith RF, Hockaday TD, Ward NI. Fasting plasma magnesium concentrations and glucose disposal in diabetes. Br Med J (Clin Res Ed) 1984;288:1032-4.
16. McBain AM, Brown IR, Menzies DG, Campbell IW. Effects of improved glycaemic control on calcium and magnesium homeostasis in type II diabetes. J Clin Pathol 1988;41:933-5.
17. Paolisso G, Sgambato S, Giugliano D, et al. Impaired insulin-induced erythrocyte magnesium accumulation is correlated to impaired insulin-mediated glucose disposal in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1988;31:910-5
18. Tosiello L. Hypomagnesemia and diabetes mellitus. A review of clinical implications. Arch Internal Med 1996;156:1143-8.
19. Kisters K, Spieker C, Tepel M, Zidek W. New data about the effects of oral physiological magnesium supplementation on several cardiovascular risk factors (lipids and blood pressure). Magnes Res 1993;6:355-60.
20. Sanjuliani AF, de Abreu Fagundes VG, Francischetti EA. Effects of magnesium on blood pressure and intracellular ion levels of Brazilian hypertensive patients. Int J Cardiol 1996;56:177-83.